Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating intraperitoneal infusion of autologous monocytes with Sylatron (peginterferon alfa-2b) and Actimmune (interferon ga…
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) [Phase 2]
Phase 2 trial ARIES evaluating rucaparib with nivolumab in selected solid tumors has been terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)? [Phase 3]
Phase 3 trial comparing surgery versus chemotherapy in recurrent ovarian cancer; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating guadecitabine plus pembrolizumab in recurrent ovarian, primary peritoneal, or fallopian tube cancer has completed w…
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer [Phase 2]
Phase 2 study evaluating oral gimatecan in platinum-resistant epithelial ovarian cancer and related abdominal cancers is ongoing with unknow…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer [Phase 3]
Phase 3 trial evaluating paclitaxel, polyglutamate paclitaxel, or observation in advanced ovarian, fallopian tube, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial update comparing olaparib alone or the combination of cediranib plus olaparib against standard chemotherapy in platinum-sensit…
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
A phase 3 trial compares olaparib alone or the combination of cediranib and olaparib versus standard chemotherapy for women with platinum-se…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer [Phase 2]
Phase 2 randomized study evaluating safety and efficacy of Pazopanib plus Gemcitabine in persistent or relapsed ovarian cancer (and related …
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Neoadjuvant Therapy for Ovarian Cancer [Phase 2]
Phase 2 neoadjuvant therapy trial for epithelial ovarian cancer with involvement of primary peritoneal cancer completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers [Phase 2]
Phase 2 pilot study evaluating durvalumab with Vigil in advanced women's cancers has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy
Clinical trial evaluating whether fallopian tube cells collected by Cytuity can determine the presence of malignancy compared with removed o…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer [Phase 3]
A Phase 3 trial comparing patupilone to doxorubicin in ovarian, fallopian tube, or peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]
This Phase 3 trial evaluates whether adding bevacizumab to a carboplatin, paclitaxel, and gemcitabine regimen after surgery improves outcome…
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II) [Phase 1, Phase 2]
Phase I/II study of oral rucaparib in patients with BRCA-mutant ovarian cancer and to a lesser extent solid tumors; study completed with res…
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Anti-PD-L1 and SAbR for Ovarian Cancer [Phase 2]
Phase 2 trial of anti-PD-L1 therapy with SAbR (stereotactic ablative radiotherapy) in recurrent epithelial ovarian/fallopian tube/primary pe…
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating trientine plus pegylated liposomal doxorubicin and carboplatin in epithelial ovarian cancer and peritoneal/ fallo…
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer [Phase 2]
A Phase 2 trial comparing PankoMab-GEX as maintenance therapy to placebo in advanced ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
A Phase 3 trial evaluating veliparib with carboplatin/paclitaxel and continuation maintenance in newly diagnosed stage III/IV high-grade ser…
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial update reporting results for nivolumab with or without ipilimumab in patients with persistent or recurrent ovarian, fallopian …
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS) [Phase 3]
Phase 3 trial investigating stratified evaluation of PDS and NACT-IDS in ovarian cancer is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer [Phase 2]
Takeda-sponsored Phase 2 trial of Niraparib in advanced, relapsed ovarian cancer (including fallopian tube and primary peritoneal cancers) h…
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 3]
Phase 3 trial evaluating paclitaxel and carboplatin versus ifosfamide in newly diagnosed, persistent, or recurrent uterine, ovarian, fallopi…
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer [Phase 1, Phase 2]
This trial update reports Phase 1/2 results for the combination of cediranib and olaparib in recurrent ovarian, fallopian tube, or primary p…
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers [EARLY_Phase 1]
Early-phase study evaluating pembrolizumab in gynecologic cancers; study completed with results posted in 2020.